Results 161 to 170 of about 3,082,887 (266)

Basilar Artery Dolichoectasia With Multiple Vessel Compression ("Vessel Sandwich") in Trigeminal Neuralgia: A Case Report and Literature Review. [PDF]

Neurosurg Pract
Corpus-Gutiérrez V, Ocampo-Navia MI, Castro Valle MDP, Ramirez-Caballero C, Barrios-Vidales E, Barajas-Solano P, Chaves-Moreno J, Daza-Ovalle A, Guzman-Ruiz N, Pérez-Pinto F.   +9 more
europepmc   +1 more source

Decoding the dynamic extracellular matrix in cancer—3D models and bioscaffolds rewire the rules of tumor progression

FEBS Letters, EarlyView.
Cancer progression is regulated by the dynamic matrix code of the tumor microenvironment, which influences cellular behavior and disease development. Importantly, matrix remodeling in three‐dimensional cancer models more accurately reflects in vivo conditions compared to conventional two‐dimensional systems.
Sylvia Mangani, Konstantinos Spanopoulos, Zoi Piperigkou, Nikos K. Karamanos   +3 more
wiley   +1 more source

Correction to "Artificial Intelligence and Automation in Evidence Synthesis: An Investigation of Methods Employed in Cochrane, Campbell Collaboration, and Environmental Evidence Reviews," "Creating Interactive Data Dashboards for Evidence Syntheses," and "Using GPT-4 for Title and Abstract Screening in a Literature Review of Public Policies: A Feasibility Study". [PDF]

Cochrane Evid Synth Methods
europepmc   +1 more source

A humanity-first approach: the solidarity of the shaken in times of war. [PDF]

Lancet Reg Health Eur
Kerbage H.
europepmc   +1 more source

Identification of a Shiga toxin A‐derived peptide internalized into Gb3 receptor‐bearing cells via interaction with the Shiga toxin B subunit

FEBS Letters, EarlyView.
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi, João C. Encarnação, Valeria Napolitano, Grzegorz Dubin, Grzegorz Popowicz, Karl Andersson, U. Helena Danielson   +6 more
wiley   +1 more source

Rethinking sustained recompensation in MASLD cirrhosis: The value of pharmacological maintenance. [PDF]

Hepatol Commun
Toshikuni N, Shimatani M.
europepmc   +1 more source

An epithelial GPR35 isoform supports tumor‐associated transcriptional and metabolic phenotypes

FEBS Letters, EarlyView.
GPR35 generates two functionally distinct isoforms with previously unresolved roles. GPR35‐short mediates immune‐cell chemotaxis, while GPR35‐long is enriched in colorectal cancer epithelium, where it supports increased metabolism, proliferation, and tumor‐associated transcriptional programs.
Jørgen D. Rønneberg, Martine Hjeltnes, Josephine Krieger, Joshua E. Elias, Maria Stensland, Kristian Holm, Xiaojun Jiang, Chuki Khangsar, Tuula A. Nyman, Arthur Kaser, Johannes R. Hov, Tom H. Karlsen, Nicole C. Kaneider, Frode L. Jahnsen, Georg Schneditz   +14 more
wiley   +1 more source

Conflict and Conflict Resolution

Refuge: Canada's Journal on Refugees, 1997
openaire   +3 more sources

Epigenetic reprogramming of lineage switching in cancer

FEBS Letters, EarlyView.
Cancer cells rarely commit to a single identity. Epigenetic mechanisms and tumor microenvironment cues push epithelial cells toward flexible, hybrid states that can shift into mesenchymal, neuroendocrine, or stem‐like fates, driving metastasis, drug resistance, and tumor heterogeneity. Targeting the epigenetic regulators behind these transitions, using
Ezgi Boyvatlı, Burcu Akman, Ezgi Bağırsakçı, Nese Atabey, Serap Erkek‐Ozhan   +4 more
wiley   +1 more source